# Alpine Income Property Trust, Inc.: financial statements, quarterly PINE · NYSE · CIK 1786117 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/pine.md) · [Financials](/companies/pine/financials.md) · [Filings](/companies/pine/filings.md) · [Insiders](/companies/pine/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pine/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [11.6 d](/filings/0001104659-26-010910.md) | [12.5](/filings/0001558370-25-005418.md) | [12.5](/filings/0001558370-25-009541.md) | [13.5](/filings/0001104659-25-101839.md) | [13.8 d](/filings/0001104659-26-010910.md) | [14.2](/filings/0001104659-26-047718.md) | [14.9](/filings/0001104659-26-086273.md) | [14.6](/filings/0001104659-26-118164.md) | [16.9 d](/filings/0001104659-26-010910.md) | [18.4](/filings/0001104659-26-047718.md) | [20.0](/filings/0001104659-26-086273.md) | [20.5](/filings/0001104659-26-118164.md) | | Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.9](/filings/0001104659-26-118164.md) | not reported | not reported | not reported | [2.1](/filings/0001104659-26-118164.md) | | Operating income | $m | [3.0 d](/filings/0001104659-26-010910.md) | [2.6](/filings/0001558370-25-005418.md) | [3.0](/filings/0001558370-25-009541.md) | [6.5](/filings/0001104659-25-101839.md) | [2.0 d](/filings/0001104659-26-010910.md) | [2.3](/filings/0001104659-26-047718.md) | [2.5](/filings/0001104659-26-086273.md) | [2.4](/filings/0001104659-26-118164.md) | [6.0 d](/filings/0001104659-26-010910.md) | [6.6](/filings/0001104659-26-047718.md) | [8.7](/filings/0001104659-26-086273.md) | [9.8](/filings/0001104659-26-118164.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | [3.6](/filings/0001104659-26-047718.md) | [4.3](/filings/0001104659-26-086273.md) | [3.9](/filings/0001104659-26-118164.md) | [4.4 d](/filings/0001104659-26-010910.md) | [4.4](/filings/0001104659-26-047718.md) | [4.6](/filings/0001104659-26-086273.md) | [4.8](/filings/0001104659-26-118164.md) | | Net income | $m | [0.3 d](/filings/0001104659-26-010910.md) | [(0.3)](/filings/0001558370-25-005418.md) | [0.2](/filings/0001558370-25-009541.md) | [3.1](/filings/0001104659-25-101839.md) | [(1.0) d](/filings/0001104659-26-010910.md) | [(1.2)](/filings/0001104659-26-047718.md) | [(1.6)](/filings/0001104659-26-086273.md) | [(1.3)](/filings/0001104659-26-118164.md) | [1.5 d](/filings/0001104659-26-010910.md) | [2.2](/filings/0001104659-26-047718.md) | [4.2](/filings/0001104659-26-086273.md) | [4.7](/filings/0001104659-26-118164.md) | | Diluted EPS | $ per share | not reported | [(0.02)](/filings/0001558370-25-005418.md) | [0.01](/filings/0001558370-25-009541.md) | [0.21](/filings/0001104659-25-101839.md) | not reported | [(0.08)](/filings/0001104659-26-047718.md) | [(0.12)](/filings/0001104659-26-086273.md) | [(0.09)](/filings/0001104659-26-118164.md) | not reported | [0.06](/filings/0001104659-26-047718.md) | [0.16](/filings/0001104659-26-086273.md) | [0.18](/filings/0001104659-26-118164.md) | | Basic EPS | $ per share | not reported | [(0.02)](/filings/0001558370-25-005418.md) | [0.01](/filings/0001558370-25-009541.md) | [0.22](/filings/0001104659-25-101839.md) | not reported | [(0.08)](/filings/0001104659-26-047718.md) | [(0.12)](/filings/0001104659-26-086273.md) | [(0.09)](/filings/0001104659-26-118164.md) | not reported | [0.07](/filings/0001104659-26-047718.md) | [0.18](/filings/0001104659-26-086273.md) | [0.19](/filings/0001104659-26-118164.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [4.0](/filings/0001104659-26-010910.md) | [5.1](/filings/0001558370-25-005418.md) | [3.3](/filings/0001558370-25-009541.md) | [2.6](/filings/0001104659-25-101839.md) | [1.6](/filings/0001104659-26-010910.md) | [6.1](/filings/0001104659-26-047718.md) | [5.0](/filings/0001104659-26-086273.md) | [1.2](/filings/0001104659-26-118164.md) | [4.6](/filings/0001104659-26-118164.md) | [2.6](/filings/0001104659-26-047718.md) | [2.8](/filings/0001104659-26-086273.md) | [11.7](/filings/0001104659-26-118164.md) | | Total assets | $m | [565](/filings/0001558370-25-000687.md) | [559](/filings/0001558370-24-005313.md) | [566](/filings/0001558370-24-009895.md) | [579](/filings/0001558370-24-013368.md) | [605](/filings/0001104659-26-010910.md) | [647](/filings/0001558370-25-005418.md) | [628](/filings/0001558370-25-009541.md) | [621](/filings/0001104659-25-101839.md) | [716](/filings/0001104659-26-118164.md) | [745](/filings/0001104659-26-047718.md) | [782](/filings/0001104659-26-086273.md) | [821](/filings/0001104659-26-118164.md) | | Total liabilities | $m | [289](/filings/0001558370-25-000687.md) | [286](/filings/0001558370-24-005313.md) | [297](/filings/0001558370-24-009895.md) | [307](/filings/0001558370-24-013368.md) | [329](/filings/0001104659-26-010910.md) | [384](/filings/0001558370-25-005418.md) | [376](/filings/0001558370-25-009541.md) | [376](/filings/0001104659-25-101839.md) | [415](/filings/0001104659-26-118164.md) | [411](/filings/0001104659-26-047718.md) | [423](/filings/0001104659-26-086273.md) | [452](/filings/0001104659-26-118164.md) | | Long-term debt | $m | [276](/filings/0001558370-25-000687.md) | [272](/filings/0001558370-24-005313.md) | [268](/filings/0001558370-24-009895.md) | [279](/filings/0001558370-24-013368.md) | [301](/filings/0001104659-26-010910.md) | [357](/filings/0001558370-25-005418.md) | [353](/filings/0001558370-25-009541.md) | [358](/filings/0001104659-25-101839.md) | [378](/filings/0001104659-26-118164.md) | [359](/filings/0001104659-26-047718.md) | [368](/filings/0001104659-26-086273.md) | [397](/filings/0001104659-26-118164.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | [100](/filings/0001558370-25-009541.md) | [100](/filings/0001104659-25-101839.md) | [100](/filings/0001104659-26-086273.md) | not reported | not reported | not reported | | Shareholders' equity | $m | [251](/filings/0001558370-25-000687.md) | [248](/filings/0001558370-24-005313.md) | [244](/filings/0001558370-24-009895.md) | [248](/filings/0001558370-24-013368.md) | [253](/filings/0001104659-26-010910.md) | [241](/filings/0001558370-25-005418.md) | [230](/filings/0001558370-25-009541.md) | [224](/filings/0001104659-25-101839.md) | [280](/filings/0001104659-26-118164.md) | [312](/filings/0001104659-26-047718.md) | [337](/filings/0001104659-26-086273.md) | [347](/filings/0001104659-26-118164.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [4.4 d](/filings/0001104659-26-010910.md) | [6.8](/filings/0001558370-25-005418.md) | [8.0 d](/filings/0001558370-25-009541.md) | [6.2 d](/filings/0001104659-25-101839.md) | [2.4 d](/filings/0001104659-26-010910.md) | [5.8](/filings/0001104659-26-047718.md) | [8.4 d](/filings/0001104659-26-086273.md) | [6.2 d](/filings/0001104659-26-118164.md) | [5.3 d](/filings/0001104659-26-010910.md) | [4.4](/filings/0001104659-26-047718.md) | [6.2 d](/filings/0001104659-26-086273.md) | [2.0 d](/filings/0001104659-26-118164.md) | | Capital expenditure | $m | [31.6 d](/filings/0001104659-26-010910.md) | [4.7](/filings/0001558370-25-005418.md) | [21.5](/filings/0001558370-25-009541.md) | [49.3](/filings/0001104659-25-101839.md) | [56.9 d](/filings/0001104659-26-010910.md) | [61.4](/filings/0001104659-26-047718.md) | [12.1](/filings/0001558370-25-009541.md) | [57.5](/filings/0001104659-25-101839.md) | [114 d](/filings/0001104659-26-010910.md) | [57.5](/filings/0001104659-26-047718.md) | not reported | not reported | | Dividends paid | $m | [4.1 d](/filings/0001104659-26-010910.md) | [4.1](/filings/0001558370-25-005418.md) | [4.1 d](/filings/0001558370-25-009541.md) | [4.2 d](/filings/0001104659-25-101839.md) | [4.5 d](/filings/0001104659-26-010910.md) | [4.5](/filings/0001104659-26-047718.md) | [4.4](/filings/0001104659-26-086273.md) | [4.4](/filings/0001104659-26-118164.md) | [4.5 d](/filings/0001104659-26-010910.md) | [5.3](/filings/0001104659-26-047718.md) | [5.6](/filings/0001104659-26-086273.md) | [6.1](/filings/0001104659-26-118164.md) | | Share repurchases | $m | [9.5 d](/filings/0001104659-26-010910.md) | [0.8](/filings/0001558370-25-005418.md) | [0.0 d](/filings/0001558370-25-009541.md) | [0.0 d](/filings/0001104659-25-101839.md) | [0.0 d](/filings/0001104659-26-010910.md) | [4.5](/filings/0001104659-26-047718.md) | [4.3 d](/filings/0001104659-26-086273.md) | [0.0 d](/filings/0001104659-26-118164.md) | [0.0 d](/filings/0001104659-26-010910.md) | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [15.7](/filings/0001558370-24-005313.md) | [15.8](/filings/0001558370-24-009895.md) | [15.6](/filings/0001558370-24-013368.md) | [14.8](/filings/0001558370-25-005418.md) | [14.8](/filings/0001558370-25-009541.md) | [15.0](/filings/0001104659-25-101839.md) | [15.9](/filings/0001104659-26-047718.md) | [15.4](/filings/0001104659-26-086273.md) | [15.4](/filings/0001104659-26-118164.md) | [16.8](/filings/0001104659-26-047718.md) | [18.3](/filings/0001104659-26-086273.md) | [18.9](/filings/0001104659-26-118164.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 17,940,667 at 2026-10-17, from the cover of the [10-Q filed 2026-10-22](/filings/0001104659-26-118164.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.